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Research Question? Call the Office of Research at our central number: 413-794-3391
Dr. Amir Lotfi of the Divi-
sion of Cardiology and the 
Heart & Vascular Service 
will serve as the national 
co-PI of a new clinical trial 
of using supersaturated 
oxygen in patients who 
have experienced a heart 
attack (also known as myo-
cardial infarction, or “MI”). 
Sponsored by ZOLL 
Circulation, Inc., USA, 
AMIHOT III Supersatu-
rated Oxygen Delivery 
in Anterior MI Patients 
will randomize anterior MI 
patients 1:1 to receive either 
PCI or PCI followed by 60 
minutes of supersaturated 
oxygen delivery. (PCI = 
percutaneous coronary 
intervention, angioplasty 
with a stent. This method 
uses a catheter to stent 
open blood vessels in the 
heart that have been nar-
rowed by plaque buildup.) 
The study hopes to start in 
mid-2021 at Baystate.
Baystate previously 
participated in the IC-HOT 
study, which studied the 
technology behind super-
saturated oxygen, a few 
years ago. The FDA has 
approved the supersatu-
rated oxygen technology. 
What prompted the 
AMIHOT III study? 
“We have become very 
good at opening up the 
blood vessels in the heart, 
and our goal is less than 
90 minutes,” explained 
Dr. Lotfi. “But one thing 
we have noticed is that 
when we open the blood 
vessels, there’s a risk of 
increased heart damage 
called reperfusion injury. 
When blood vessels are 
opened too suddenly, a 
gush of blood may activate 
a negative effect on 
the heart muscle, which 
can cause arrhythmias 
(irregular heartbeat) and/or 
possible lifelong damage 
to the heart muscle. Many 
people have been working 
on a better way to protect 
the heart to help reduce 
incidents like this. There 
are ongoing studies and 
have been multiple prior 
studies using different 
technologies to see if they 
can help prevent reperfu-
sion injury.”
AMIHOT III uses 
supersaturated oxygen in 
the largest blood vessel in 
the heart (the left anterior 
descending coronary 
artery). But how does oxy-
gen get “supersaturated”?
“Blood is taken from the 
body and infused with a 
high saturation of oxygen 
using a special console,” 
said Dr. Lotfi. “This is using 
the technology approved 
in the IC-HOT study. From 
there, it is re-infused to the 
blood vessel of the heart.” 
In addition to serving as 
local site PI at Baystate, Dr. 
Lofti joined as national co-
principal investigator by Dr. 
James Blankenship of the 
University of New Mexico. 
The study is currently in 
the U.S. and Canada and 
hopes to move internation-
ally to Europe. 
“The biggest goal is to 
see if this therapy leads 
to less muscle damage 




Research study to reduce reperfusion injury in heart attack patients
Dr. Amir Lotfi
New administrative space at 3601 Main Street
(Continued on page 2)
Researchers and 
Baystate staff may 
have many ideas on 
the job, like a tool or an 
improved design that 
may make their job more 
efficient. What do they 
do with these ideas? 
How do they put them 
into effect?
These ideas are 
considered intellectual 
property (IP). IP refers 
to intangible rights 
protecting the products 
of human intelligence 
and creation. Inven-
tions or creations 
typically must be (1) 
novel, (2) useful, and (3) 
non-obvious.
“IP is problem solving 
by the people who are 
on the front lines,” said 
Todd Keiller, MBA, Tech-
nology Transfer Officer. 
“We are always trying to 
Baystate researchers encouraged to 
submit ideas for intellectual property
(Continued on page 3)
Visitors to 3601 Main 
Street may have noticed 
a new recent addition on 
the third floor. What was 
once empty shell space 
is now the new home to 
the Baystate HRPP/IRB, 
Sponsored Programs 
Administration (SPA), 
Research Finance, the 
Research IT Director, and 
the Director of Operations 
and Budget.  
The space can hold a 
total of 15-20 staff mem-
bers and is a result of the 
Mass Life Sciences Center 
grant awarded to Baystate 
Health in the summer of 
2019. 
“The goal of the 
Mass Life project is to 
(Top right) The layout is similar to 
that of the rest of the 3rd floor at 
3601 Main Street -- central cubicles 
surrounded by management 
offices. (Bottom right) The main 
door into the new space is just 
off the main hallway at 3601 Main 
Street on the 3rd floor, right near 
the Learning Community/kitchen.
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Compliance Corner with Chief Research Compliance Officer Jennifer Pacheco, 
MPH, CIM, CIP, and Chief Compliance & Privacy Officer, Renee Wroth, Esq.
Do you know about 
Baystate’s policy on 
Interactions with Industry? 
If you are asked to speak 
at a professional event 
outside of Baystate, you 
should take the time to 
read this policy to under-
stand Baystate’s require-
ments for its employees’ 
outside engagements. 
This policy describes 
the assessment process 
utilized to ensure that 
financial conflicts of interest 
do not influence decisions 
regarding patient care, the 
integrity of research, and 
the quality of the education 
and training of healthcare 
professionals. This policy is 
designed to protect you, as 
healthcare professionals, 
because participating in 
speaker programs are an 
area of heightened scrutiny 
by state and federal 
government.
Speaking engagements 
to disseminate knowledge 
from clinical or research 
developments, such 
as CME events, grand 
rounds, lectures for 
government or higher 
education, and academic 
centers, are allowable 
under the policy. These 
talks should be based on 
peer-reviewed research, 
scientific, or professional 
experience and should use 
materials you developed 
without Industry input or 
requirement for approval. 
 On the other hand, 
the policy prohibits 
promotional speaking 
engagements because 
they are an extension 
of marketing activities. 
Prohibited speaking 
engagements are typically 
characterized by one or 
more of the following:
1) The presentation 
conveys information about 
Industry’s products or their 
drug classes;
2) The speaker appears 
to act as an agent or 
spokesperson on behalf 
of industry to promote 
product information;
3) The industry entity 
controls the content of 
the presentation, which 
may include creating or 
having final approval over 
the slides or presentation 
materials or setting limits 
on the scope of discussion; 
or
4) Industry controls the 




industry or related entities 
should be reviewed by 
Baystate’s Conflict of 
Interest Committee. When 
submitting, please include 
the following information:
• Whether your Chair or 
Service Line Leader has 
reviewed and approved 
the engagement.
• Detailed information 
about the speaking 
engagement including:
- A copy of the 
advertisement for the event 
in particular, whether it is 
being promoted from the 
company’s educational arm 
or their sales arm
- A copy of the 
presentation
- Where the event is 
taking place
- Who is the intended 
audience
- What you are being 
paid or reimbursed (travel, 
speaking, etc.)
- Whether you have or 
will receive other funding 
(i.e., research or consulting) 
from the company, either 
personally or in your 
capacity at Baystate; 
- A copy of the speaking 
agreement
- Whether the company’s 
and other competing 
comparable products will 
be discussed
- Whether CMEs are 
offered
- Whether you have 
decision-making authority 
over Baystate’s use of any 
of the company’s products 
- Whether you or the 
company will create the 
slide deck; and finally,
- Whether the company 
has final approval of the 
content of the talk.
Questions? Call 413-794-
3458 or email Jennifer.
Pacheco@baystatehealth.
org.
Jennifer Pacheco, MPH, CIM, 
CIP
Renee Wroth, Esq.
accelerate the growth of 
Baystate Health’s capac-
ity to perform efficient 
and compliant clinical 
trials, speed scientific 
advances, and bring 
innovative treatments to 
patients,” said Jennifer 
Pacheco, MPH, CHRC, 
CIM, CIP, Director of 
Healthcare Research 
Compliance and Chief 
Research Compliance 
Officer.
“One of the objec-
tives of project included 
refurbishing space in 
Baystate Health’s 3601 
Main Street building in 
Springfield for clinical 
research personnel.”
The area includes staff 
cubicle space, offices for 
management, a restroom, 
and a small breakroom. 
“The benefit of this 
new space is that all the 
research administrative 
functions are now in one 
area,” added Brenda 
Wrobel, Director of 
Operations and Budget, 
Office of Research. “The 
grant allows for capital 
improvements that would 
enhance job creation 
from prior state invest-
ments in life sciences 
degree programs at local 
community colleges.”
“A few things I like 
about our new work-
space are our spacious 
work areas and quieter 
work environment. It 
makes it easier to focus 
on our tasks throughout 
the day. Also, everything 
is fresh and new,” said 
Jessica Parente, MPH, a 
Grants Manager.
This administrative 
space at 3601 Main 
Street, along with the 
Clinical Trials Unit at 
80 Wason Avenue, will 
support impactful clinical 
research and expand 
collaborations with 
academic and industry 
partners. 
News from UMass CCTS 
INTRODUCING THE 
LIFE COURSE VISUAL 
TOOLKIT
The innovative National 
Center for Advancing 
Translational Science 
(NCATS) Life Course 
Research Visual Toolkit 
was created to advance 
the recommendations 
outlined in, Charting 
the Life Course: 
Emerging Opportunities 
to Advance Scientific 
Approaches Using Life 
Course Research. The 
Life Course Research 
Visual Toolkit serves to 
increase knowledge about 
innovative life course 
research methods by 
providing content that 
is widely available and 
accessible to trainees 
and researchers across 
multiple disciplines. The 
archive includes 6 full 
webinars with more than 15 
national and international 
experts and 32 shorter 
education skills building 





A structured guidance 
session that engages 
community members, 
patients, and other non-
academic stakeholders 
in biomedical and 
clinical research, where 
they may serve as 
expert consultants and 
provide feedback from a 
community perspective 
to enhance the relevance 
and utility of research 
projects. 
Learn more at https://bit.
ly/3kzEMdq.
(Above) The break room has 
counter space, a mini fridge, and 
seating. (Below) A close up of one 
of the new cubicles.
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think of inventions or new 
creations to better the 
care we provide.”
Previous examples of IP 
generated by BH employ-
ees include:
1) Novel new design of 
Percutaneous Endoscopic 
Gastrostomy (PEG) that 
gets the tube stable and 
secure (inventor: Tovy 
Kamine, MD)
2) A disposable, 
one-time use, lighted rib 
separator that will allow 
better visualization during 
surgery (inventor: Tovy 
Kamine, MD)
3) A foley catheter 
design modification to 
reduce introduced 
infections (inventor: Mary 
Butitta, RN)
Baystate Health’s Office 
of Technology Transfer is 
responsible for identifying 
clinically and commercially 
significant research activi-
ties arising at Baystate, 
ensuring that such devel-
opments are protected via 
the most appropriate route 
(e.g. patents, copyrights, 
trademarks, etc.). They 
work with industry profes-
sionals to promote the 
development of beneficial 
products from Baystate’s 
research and inventions.
Any Baystate Health 
employee can submit an 
idea through the forms 
available online (https://
bit.ly/3e4kjJE). Once ideas 
are submitted, they are 
reviewed by Baystate’s 
Technology Transfer Office 
and brought to Baystate’s 
IP Committee.  
“Our IP Committee 
makes decisions regard-
ing ownership of IP and 
distribution of licensing 
income within Baystate’s 
IP guidelines, which are 
very generous to our 
employee-inventors,” 
adds Christian Lagier, 
VP of Digital Innovation 
at Baystate Health, who 
chairs the IP Committee. 
“This Committee meets 
on a quarterly basis and is 
happy to support Baystate 
inventors and welcome 
their ideas.”
Proposals that are 
accepted by the com-
mittee are supported by 
way of funding intellectual 
property legal processes 
via a patent or copyright, 
and then the Tech Transfer 
Office helps seek a com-
mercial pathway for that 
invention.
If you have any ques-
tions about IP or would 
like to learn more, please 
email todd.keiller@gmail.
com.
(Continued from page 1)
News from Tufts CTSI
INVESTIGATORS: 
COVID-19 SURVIVORS 
ARE WAITING TO HEAR 
FROM YOU!
Are you conduct-
ing research related to 
COVID-19? 
Over 1,000 conva-
lescent patients have 
signed up for the National 
COVID-19 Survivors 
Registry, a database to 
connect COVID-19 sur-
vivors with opportunities 
to participate in research 
about how people 
recover from COVID-19. 
It can be accessed at bit.
ly/3dNZy4u.
Investigators and 
study teams across Tufts 
Medical Center, Tufts Uni-
versity, and Tufts CTSI’s 
Clinical Research Network 
(including Baystate 
Health) are invited to con-
tact us to discuss registry 
access for their research. 
Interested? Please email 
Timothy Bilodeau, MBA, 
Program Administrative 
Director of the Multi-site 
Clinical Research Center 
and Recruitment and 
Retention Support Unit, at 
tbilodeau@tuftsmedical-
center.org. 
Please contact Amy 
West with any questions 
at awest@tuftsmedical-
center.org.
Welcome to our new research staff!
IRB/HRPP:
- Shemetra Owens, HRPP 
Manager 
CTO:
- Jennifer Dawood, 
Clinical Research 
Assistant II 
- Andrea Munsey, Clinical 
Research Regulatory 
Specialist 
- Nickolas Vernadakis, 
BS, Clinical Research 
Assistant II
- Viorika Nelson, DNP, 
FNP-C, Clinical Trial 
Specialist 
SPA:
- Emma Mirabile, Grants 
Administrator, SPA 
- Nicole Ferrari, MS, CIP, 
IRB Reliance Analyst
OFFICE OF RESEARCH: 
- Ashley Negron, Staff 
Assistant




- Simon Dufresne, 
Veterinary Technician
OTHER DEPARTMENTS: 
- Michelle Hart, 
Regulatory Specialist, 
Critical Care
- Rae Lynn DeFeo, 
Sr. Clinical Research 
Coordinator, Critical Care
- Sirisha Nouduri, Clinical 
Research Assistant II, 
Neurology
- Jillian Tozloski, Clinical 
Research Assistant II, 
Emergency Medicine







MD Shared Decision-Making 
for the promotion of Medica-
tion for Opiate Use Disorder 
(MOUD) in the Emergency 
Department (SDM-4-MOUD). 
Baystate Health, Inc., RPAP.
OB/GYN
MEGAN MILLER, MD Support 
Models for Addiction Related 
Treatment (SMART) Trial of 
Opioid Use Disorder in Preg-




O’NEIL GREEN, MD A 
Randomized, Double-Blind, 
Placebo-Controlled, Parallel-
Group, Multi-Center Study to 
Assess the Efficacy, Safety, 
and Tolerability of INS1007 
Administered Once Daily for 




PAUL PIRRAGLIA, MD 
A multicenter, adaptive, 
prospective, randomized trial 
evaluating the efficacy and 
safety of antithrombotic strate-
gies in patients with COVID-19 
following hospital discharge. 
Covance, Inc., NHLBI.
ONCOLOGY
TASHANNA MYERS, MD 
Mersana Therapeutics Inc. 
MER-XMT-1536-1 A Phase 1b/2, 
First-in-Human, Dose Escala-
tion and Expansion Study 
of XMT-1536 In Patients with 
Solid Tumors Likely to Express 
NaPi2b (GOG 3048). Mersana 
Therapeutics, Inc. 
Aravive Inc., AVB500-OC-004 
A Phase 3, Randomized, Dou-
ble-Blind, Adaptive, Placebo/
Paclitaxel-Controlled Study of 
AVB-S6-500 in Combination 
with Paclitaxel in Patients with 
Platinum-Resistant Recurrent 
Ovarian Cancer (GOG 3059). 
Aravive, Inc. 
HCQ
MIHAELA STEFAN, MD 
University of Massachusetts 
Center for Clinical and Trans-
lational Science. University of 
Massachusetts Medical School, 
National Institutes of Health 
(NIH).
PVLSI
SALLIE SCHNEIDER, PHD 
E2-PATH assay for assess-
ment of breast cancer risk and 
treatment. Mass Life Sciences 
Center.
(Above left) Todd Keiller, MBA, Transfer Officer. (Above right) Christian 
Lagier, VP of Digital Innovation, Baystate Health and Executive 
Director, TechSpring. Photo by Suzanne Larocque, Business Betties.
The Office of Research bids a fond farewell 
to Allison Billeter, and thanks her for her 
outstanding stewardship of The Innovator. 
She will be transitioning to her new role as 
a Communications Specialist II this summer. 
Good luck in your next chapter, Allie!
Best wishes to Allison Billeter
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Meet the Researcher
Name: Paul A. Pirraglia, MD, MPH
Title/Academic Rank: Chief, Division 
of General Medicine and Community 
Health/Associate Professor of 
Medicine
Department: Medicine
Number of years at Baystate: 2 
years in September
What research training do you 
have? General Internal Medicine 
Fellowship and MPH in Clinical 
Effectiveness
What got you interested in 
research overall? I’ve been 
interested in research since I was 
an undergraduate. As a psychology 
major, I had work study jobs running 
rats in mazes (for real) and on a 
study of cognitive function in families 
with Huntington’s. My first two jobs 
after graduating were as a research 
assistant, first in the Laboratory 
for the Study of Human Ingestive 
Behavior at Johns Hopkins Hospital 
then on a study of the management 
of mean arterial pressure during 
cardiopulmonary bypass on 
cardiovascular, neurological, and 
cognitive outcomes at Cornell 
University Medical College. I 
continued my work with the team 
at Cornell through medical school 
which help me earn Honors in 
Research with my MD. I continued 
to be involved in research in 
residency and that led to doing 
a research fellowship. Each step 
was interesting and gratifying and 
helped lead to the next.
What is your area of research? 
Most of my research was focused 
on the overlap of physical 
conditions and mental health, but 
I was involved in a lot of other 
areas which is the beauty of being 
a generalist. I am moving now 
toward work related to social 
determinants of health as this is 
a major concern in our Health 
Centers.  I’m also involved in some 
COVID-related research.
How do you see your research 
improving care for patients? My 
work has been mostly practical 
regarding common conditions and 
systems of care, so I see a direct 
relationship between my research 
and care.
What have been some of your 
favorite research projects to 
date that you have organized/
participated in? My work on serious 
mental illness particularly on reverse 
integration of primary care into the 
mental health setting was my favorite 
(thus far!).
Do you have any awards? For 
research, I have received the 
following:
- American Psychosomatic Society 
Physician-Scientist Fellowship, 2004
- Melvin D. Hoffman Scholar Award 
for Research, Brown Medical School, 
2001
- Trainee Investigator Award for 
Excellence in Scientific Research, 
American Federation for Clinical 
Research, 1994
- Best Abstract by a Student, Eastern 
Section American Federation for 
Clinical Research, 1993
What do you like most about your 
job? Variety! As a Division Chief, in 
addition to promoting and engaging 
in research, I am involved in 
administrative work, clinical practice, 
and education, all of which is about 
figuring out better ways to take care 
of patients.
What do you do to unwind outside 
of work? I read (mostly science 
fiction), bike, cook, and ski.
Paul A. Pirraglia, MD, MPH
Contact Baystate’s Health Science Library for more information at libraryinfo.bhs.org/home
Kashef MA, Lotfi AS. Evidence-Based 
Approach to Out-of-Hospital Cardiac 
Arrest. Curr Treat Options Cardiovasc 
Med. 2021;23(6):43. doi: 10.1007/s11936-
021-00924-3. Epub 2021 May 10.
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Breast Milk in Infectious Disease. Clin 
Perinatol. 2021 Jun;48(2):359-378. doi: 
10.1016/j.clp.2021.03.008.
Vaidya R, Visintainer P, Singh R. Tidal 
volume measurements in the delivery 
room in preterm infants requiring posi-
tive pressure ventilation via endotra-
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2021 Jun 10:1–6. doi: 10.1038/s41372-
021-01113-7. Epub ahead of print.
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Evaluation of Clinical HEART Score 
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in Emergency Department Chest Pain 




Doty E, DiGiacomo S, Gunn B, Westafer 
L, Schoenfeld E. What are the clinical 
effects of the different emergency 
department imaging options for sus-
pected renal colic? A scoping review. 
J Am Coll Emerg Physicians Open. 
2021 Jun 16;2(3):e12446. doi: 10.1002/
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Daniel NJ, Patel SB, St Marie P, Schoen-
feld EM. Rethinking hiker preparedness: 
Association of carrying “10 essentials” 
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among day-hikers. Am J Emerg Med. 
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in Patients with Advanced COPD: A 
Cohort Study. Ann Am Thorac Soc. 2021 
Jun 25. doi: 10.1513/AnnalsATS.202007-
859OC. Epub ahead of print.
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Talbot HK, Lindsell CJ, Steingrub JS, 
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Monto AS, Martin ET, Malani A, Zimmer-
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Effectiveness of Pfizer-BioNTech and 
Moderna Vaccines Against COVID-19 
Among Hospitalized Adults Aged 
≥65 Years - United States, January-
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10.15585/mmwr.mm7018e1.
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AA, Douin DJ, Prekker ME, Erickson HL, 
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A, Exline MC, Files DC, Gibbs KW, Rice 
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Chang SY, Henning DJ, Wilson JG, Self 
WH, Patel MM; IVY Network Investiga-
tors. Adults Hospitalized with COVID-19 
-United States, March-June and Octo-
ber-December 2020: Implications for 
the Potential Effects of COVID-19 Tier-1 
Vaccination on Future Hospitalizations 
and Outcomes. Clin Infect Dis. 2021 
May 12:ciab319. doi: 10.1093/cid/ciab319. 
Epub ahead of print.
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Aboodi M, Baughman AH, Brown SM, 
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Influenza and Other Viruses in the 
Acutely Ill (IVY) Network. Influenza 
Vaccine Effectiveness for Prevention 
of Severe Influenza-Associated Illness 
among Adults in the United States, 
2019-2020: A test-negative study. Clin 
Infect Dis. 2021 May 20:ciab462. doi: 
10.1093/cid/ciab462. Epub ahead of 
print.
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on influenza vaccine effectiveness 
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Epub ahead of print.
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estimated dry weight in dialysis patients 
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best. J Nephrol. 2021 May 24. doi: 
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ahead of print.
Peacock-Chambers E, Paterno MT, 
Kiely D, Fioroni T, Byatt N, Fried-
mann PD. Engagement in perinatal 
outpatient services among women in 
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ahead of print.
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of print.
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ajog.2021.04.235. Epub ahead of print.
Al-Mansour MR, Wu J, Gagnon G, Knee 
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of a simple technique of volumetric 
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Surg Endosc. 2021 Apr 15. doi: 10.1007/
s00464-021-08476-0. Epub ahead of 
print.
Blanchard RD, Belforti RK. Evaluation of 
a Health Professions Teaching Acad-
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doi: 10.1097/CEH.0000000000000357. 
Epub ahead of print.
Artenstein AW. A half-century of 
meningococcal vaccines. Vaccine. 2021 
Apr 22;39(17):2475-2478. doi: 10.1016/j.
vaccine.2021.03.024. Epub 2021 Mar 19.
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